Suppr超能文献

评估特发性声门下狭窄的多次腔内类固醇注射后的副作用。

Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis.

机构信息

Istanbul Training and Research Hospital, Otolaryngology Head and Neck Surgery Clinic, Istanbul, Turkey.

Department of Otolaryngology, Massachusetts Eye and Ear, Boston, MA, USA.

出版信息

Eur Arch Otorhinolaryngol. 2021 Feb;278(2):445-450. doi: 10.1007/s00405-020-06371-3. Epub 2020 Sep 18.

Abstract

PURPOSE

To assess the incidence and severity of 12 systemic side effects of serial intralesional steroid injections (SILSI) in patients with idiopathic subglottic stenosis (iSGS).

METHODS

This retrospective study included patients with iSGS who underwent SILSI with Triamcinolone 40 mg/dL. After SILSI, the patients were asked to answer 12 questions regarding frequently encountered systemic side effects of steroids. Each answer was rated as mild, moderate, or severe. Descriptive statistics were used to analyze and present the findings.

RESULTS

The study included 49 patients (42 female and 7 male) with a mean age of 59.1 years (range 21-83 years). Post-SILSI treatment, 27 (55%) reported experiencing side effects while 22 (45%) patients reported no side effects. The most frequent side effect reported in women of reproductive age (n: 8) was menstrual irregularities (3/8, 37%). Other frequently reported side effects were feeling joyful and sleeping difficulties, each reported by 30% of the patients. All side effects resolved after the completion of SILSI.

CONCLUSIONS

SILSI can be administered with minimal tolerable side effects. Clinicians should make their patients aware of the most frequent side effects. Special attention should be given to women of reproductive age to inform them of the possibility of menstrual irregularities during SILSI.

摘要

目的

评估特发性声门下狭窄(iSGS)患者接受曲安奈德 40mg/dL 序贯腔内类固醇注射(SILSI)后 12 种全身副作用的发生率和严重程度。

方法

这是一项回顾性研究,纳入了接受 SILSI 治疗的 iSGS 患者。SILSI 后,患者需回答 12 个关于类固醇常见全身副作用的问题。每个答案的严重程度分为轻度、中度或重度。采用描述性统计方法对结果进行分析和呈现。

结果

该研究纳入了 49 名患者(42 名女性和 7 名男性),平均年龄为 59.1 岁(范围 21-83 岁)。27 名(55%)患者在 SILSI 治疗后报告出现副作用,22 名(45%)患者报告无副作用。处于生育年龄的女性(n=8)报告最常见的副作用是月经不规律(3/8,37%)。其他常见的副作用是感觉快乐和睡眠困难,各有 30%的患者报告。所有副作用均在 SILSI 治疗完成后消失。

结论

SILSI 可在可耐受的最小副作用下进行。临床医生应让患者了解最常见的副作用。应特别关注生育年龄的女性,告知其在 SILSI 期间可能出现月经不规律的情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验